Related Experiment Video
Updated: Jul 13, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Speeding up coeliac disease diagnosis in the developing countries
S Crovella1, L Brandao, R Guimaraes
1Department of Reproductive and Developmental Sciences, University of Trieste, Institute of Child Health I.R.C.C.S. Burlo Garofolo, Italy.
Rapid tests for anti-transglutaminase antibodies accurately identified coeliac disease in Brazil. These cost-effective assays are suitable for non-specialized use in developing countries, enabling wider screening for this condition.
Area of Science:
- Immunology
- Gastroenterology
- Public Health
Background:
- Anti-transglutaminase antibodies are key biomarkers for active coeliac disease.
- Limited access to antibody assays in developing nations hinders coeliac disease screening.
- Economical and accessible diagnostic tools are crucial for early detection.
Purpose of the Study:
- To assess coeliac disease prevalence in urban and impoverished sub-urban populations in Recife, Brazil.
- To evaluate the efficacy of two rapid anti-transglutaminase antibody tests using serum and whole blood.
- To determine the feasibility of these rapid tests for coeliac disease screening in resource-limited settings.
Main Methods:
- Analyzed 1074 individuals (university students and residents of impoverished areas) using two rapid anti-transglutaminase antibody tests.
- Confirmed positive rapid test results with anti-transglutaminase enzyme-linked immunosorbent assay (ELISA), HLA DQ2/8 typing, and intestinal biopsy.
- Compared test performance in urban versus sub-urban impoverished populations.
Main Results:
- Both rapid assays detected 25 positive cases out of 1074 participants.
- ELISA confirmed 9 cases (0.84% prevalence) with typical coeliac disease lesions.
- Seven confirmed coeliac disease patients were asymptomatic; two had recurrent abdominal pain.
Conclusions:
- Rapid anti-transglutaminase antibody assays are accurate and cost-effective for identifying coeliac disease.
- These tests demonstrate high potential for use by non-specialized personnel in developing countries.
- The study supports the implementation of these rapid assays for widespread coeliac disease screening in resource-limited settings.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Serum Laboratory Studies, Stool Test, Breath Test
Gastrointestinal Motility Disorders
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and solid...
